drugset / Trial / NCT04959812
Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Sufentanil
RandomizedCrossoverSingle-blindBasic science
Summary
This study will examine how sufentanil (a commonly used pain medication) will alter responses to simulated blood loss in humans. To simulate blood loss in the research laboratory, participants will complete a test with their lower body in a custom-designed vacuum chamber for a brief period of time.
Timeline
- Start
- 2022-03-01
- Primary completion
- 2023-09-08
- Completion
- 2023-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sufentanil | Other / unclassified | 30 ug | Subcutaneous |
Indications
No indication recorded.